Silo Pharma Raises ~$815,000 in Private Placement Priced at $1.50
SILO sits 28% above its 52-week low of $1.1 on light trading volume (0.2× avg).
Summary
Silo Pharma closed a private placement of 136,005 shares at $1.50 and 430,661 pre-funded warrants at $1.4999, raising about $815,000 net for working capital.
Key Events · Financing and Capital Events · SILO
-
Private Placement Closes at $1.50
136,005 shares sold at $1.50 and 430,661 pre-funded warrants at $1.4999 per warrant, for up to 566,666 shares of common stock in aggregate.
-
Net Proceeds of ~$815,000
Net proceeds are expected to be approximately $815,000 after placement agent fees and estimated offering expenses, earmarked for working capital and general corporate purposes.
-
Pre-Funded Warrants Immediately Exercisable
Warrants carry a $0.0001 exercise price and are exercisable immediately until fully exercised, with 4.99% beneficial ownership blockers (up to 9.99% with 61 days' notice).
-
Resale Registration Deadline
Under the registration rights agreement dated November 5, 2026, the company must file a resale registration statement within 30 days and have it effective within 60 days (90 days on full SEC review).
Analysis · SILO · Life Sciences
Silo Pharma sold 136,005 shares at $1.50 plus 430,661 pre-funded warrants at $1.4999 each, bringing in roughly $815,000 net for working capital. The pre-funded structure lets buyers take economic exposure without tripping the 4.99%/9.99% ownership caps, and the $0.0001 strike means those shares are effectively already paid for — so the full 566,666 shares are dilution now, not contingent on future exercises. Against a $2.1M market cap this is a meaningful capital injection that extends runway, but it comes at a price above today's $1.4099 quote, so the buyers paid up relative to the current market. The company must file a resale registration statement within 30 days and get it effective within 60 (90 on full review), which will make the overhang tradable.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SILO was trading at $1.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.1M. The 52-week trading range was $1.10 to $10.43. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.